Antibiotic penetration into lung tissues.
作者信息
Honeybourne D
出版信息
Thorax. 1994 Feb;49(2):104-6. doi: 10.1136/thx.49.2.104.
Abstract
摘要
相似文献
1
Antibiotic penetration into lung tissues.抗生素在肺组织中的渗透。
Thorax. 1994 Feb;49(2):104-6. doi: 10.1136/thx.49.2.104.
2
Penetration of minocycline hydrochloride into lung tissue and sputum.盐酸米诺环素在肺组织和痰液中的渗透情况。
Chemotherapy. 2001 Jan-Feb;47(1):1-9. doi: 10.1159/000048494.
3
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections.吸入性脂质体阿米卡星在慢性铜绿假单胞菌肺部感染中的生物膜穿透、触发释放及体内活性
J Antimicrob Chemother. 2008 Apr;61(4):859-68. doi: 10.1093/jac/dkn059. Epub 2008 Feb 27.
4
The site concentrations of antimicrobial agents in the lung.肺部抗菌药物的局部浓度。
J Antimicrob Chemother. 1992 Sep;30(3):249-60. doi: 10.1093/jac/30.3.249.
5
Antibiotic pharmacokinetic considerations in pulmonary infections.
Semin Respir Infect. 1991 Sep;6(3):168-82.
6
Relation between amoxicillin concentration in sputum of COPD patients and length of hospitalization.COPD 患者痰液中阿莫西林浓度与住院时间的关系。
COPD. 2011 Apr;8(2):66-70. doi: 10.3109/15412555.2011.558863.
7
[Kinetics of antibiotic distribution in the bronchopulmonary area].[抗生素在支气管肺区域的分布动力学]
Rev Pneumol Clin. 1996;52 Suppl 2:S43-6.
8
Pulmonary disposition of antimicrobial agents: methodological considerations.
Antimicrob Agents Chemother. 1992 Jun;36(6):1171-5. doi: 10.1128/AAC.36.6.1171.
9
Pharmacokinetics of antibiotics in the lungs.
Eur Respir J. 1990 Jun;3(6):715-22.
10
[Bronchopulmonary aminochlorthenoxycycline levels in experimental burns of the respiratory tree].[呼吸道实验性烧伤中支气管肺组织的氨氯四环素水平]
Arch Sci Med (Torino). 1973 Apr-Jun;130(2):151-3.
引用本文的文献
1
Management Strategies for Chronic Suppurative Otitis Media and Why They Fail.慢性化脓性中耳炎的管理策略及其失败原因
J Assoc Res Otolaryngol. 2025 Jun 16. doi: 10.1007/s10162-025-00996-z.
2
Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling.使用基于生理的药代动力学模型预测多粘菌素B、阿米卡星和舒巴坦的组织暴露量。
Front Microbiol. 2024 Oct 7;15:1435906. doi: 10.3389/fmicb.2024.1435906. eCollection 2024.
3
Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery.从病原体和疾病进程的角度应对非结核分枝杆菌肺病的挑战：药物研发和投送方面的创新。
Respir Res. 2022 Dec 24;23(1):376. doi: 10.1186/s12931-022-02299-w.
4
Synergistic effect of low-frequency ultrasound and antibiotics on the treatment of Klebsiella pneumoniae pneumonia in mice.低频超声与抗生素对肺炎克雷伯菌肺炎小鼠治疗的协同作用。
Microb Biotechnol. 2022 Nov;15(11):2819-2830. doi: 10.1111/1751-7915.14134. Epub 2022 Aug 24.
5
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol-An All-Inclusive Guide for Clinicians.新型抗革兰氏阴性菌抗生素的微生物学、临床及药代动力学/药效学特征：β-内酰胺/β-内酰胺酶抑制剂联合制剂及头孢地尔——临床医生综合指南
Pharmaceuticals (Basel). 2022 Apr 12;15(4):463. doi: 10.3390/ph15040463.
6
Comparison of oral, nebulized and combination antibiotic treatment of Bordetella bronchiseptica in baboons (Papio spp.).比较口服、雾化和联合抗生素治疗绢毛猴（Papio spp.）支气管败血波氏杆菌。
J Vet Pharmacol Ther. 2021 Sep;44(5):836-841. doi: 10.1111/jvp.12975. Epub 2021 May 8.
7
Deaths Associated with Pneumonic Plague, 1946-2017.1946 - 2017年与肺鼠疫相关的死亡病例
Emerg Infect Dis. 2020 Oct;26(10):2432-2434. doi: 10.3201/eid2610.191270.
8
Effect of an antimicrobial drug on lung microbiota in healthy dogs.一种抗菌药物对健康犬类肺部微生物群的影响。
Heliyon. 2019 Nov 14;5(11):e02802. doi: 10.1016/j.heliyon.2019.e02802. eCollection 2019 Nov.
9
Biological Obstacles for Identifying - Correlations of Orally Inhaled Formulations.识别经口吸入制剂相关性的生物学障碍
Pharmaceutics. 2019 Jul 5;11(7):316. doi: 10.3390/pharmaceutics11070316.
10
Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future.β-内酰胺类抗生素的药代动力学：从过去获取线索以助力未来长效口服药物的研发。
ACS Infect Dis. 2018 Oct 12;4(10):1439-1447. doi: 10.1021/acsinfecdis.8b00160. Epub 2018 Sep 10.
本文引用的文献
1
Lung distribution and pharmacokinetics of aerosolized tobramycin.
Am Rev Respir Dis. 1993 May;147(5):1279-82. doi: 10.1164/ajrccm/147.5.1279.
2
Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.口服给药后环丙沙星和洛美沙星在支气管肺泡中的浓度比较。
Respir Med. 1993 Nov;87(8):595-601. doi: 10.1016/s0954-6111(05)80262-8.
3
Plasma and sputum erythromycin concentrations in chronic bronchitis.慢性支气管炎患者血浆及痰液中的红霉素浓度
Thorax. 1980 Jun;35(6):441-5. doi: 10.1136/thx.35.6.441.
4
Penetration of antibiotics into the respiratory tree.抗生素在呼吸道树中的渗透。
J Antimicrob Chemother. 1981 Sep;8(3):171-4. doi: 10.1093/jac/8.3.171.
5
Antibiotic entry into human polymorphonuclear leukocytes.抗生素进入人多形核白细胞的过程。
Antimicrob Agents Chemother. 1982 Mar;21(3):373-80. doi: 10.1128/AAC.21.3.373.
6
Membrane transport of clindamycin in alveolar macrophages.克林霉素在肺泡巨噬细胞中的膜转运
Antimicrob Agents Chemother. 1982 Feb;21(2):241-7. doi: 10.1128/AAC.21.2.241.
7
Penetration of antibiotics into respiratory secretions.抗生素在呼吸道分泌物中的渗透。
Rev Infect Dis. 1981 Jan-Feb;3(1):67-73. doi: 10.1093/clinids/3.1.67.
8
Uptake of antibiotics by human alveolar macrophages.人肺泡巨噬细胞对抗生素的摄取。
Am Rev Respir Dis. 1984 Jun;129(6):933-7. doi: 10.1164/arrd.1984.129.6.933.
9
Penetration of cefaclor into bronchial mucosa.头孢克洛在支气管黏膜中的渗透情况。
Thorax. 1984 Nov;39(11):813-7. doi: 10.1136/thx.39.11.813.
10
The use of combinations of trimethoprim and sulphonamides in the treatment of chest infections.甲氧苄啶与磺胺类药物联合用于治疗胸部感染。
J Antimicrob Chemother. 1983 Nov;12(5):423-34. doi: 10.1093/jac/12.5.423.
Zotero 插件